Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 5, 2001, Pages 1045-1050

  Troger, J ^a   Neyer, S ^a   Heufler, C ^a   Huemer, H ^a   Schmid, E ^a   Griesser, U ^a   Kralinger, M ^a   Kremser, B ^a   Baldissera, I ^a   Kieselbach, G ^a  

^a Universitätsklinik für Augenheilkunde Innsbruck   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLYCINE; NEUROTRANSMITTER; SUBSTANCE P; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NERVE CELL EXCITABILITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RADIOIMMUNOASSAY; RAT; RETINA INJURY; RETINA NEOVASCULARIZATION; STREPTOZOCIN DIABETES;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; MALE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0035072761     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Tachykinins
2. Neurotransmitter functions of mammalian tachykinins
3. Substance P and neurokinins
4. Localization of substance P-like immunoreactivity within the monkey retina
5. Identification and localization of biologically active peptides in the vertebrate retina
6. Substance P-immunoreactive retinal ganglion cells and their central axon terminals in rabbit
7. Colocalization of GABA in retinal ganglion cells: A computer-assisted visualization
8. Substance P-immunoreactive neurons in the human retina
9. Demonstration of a substance P-like immunoreactivity in retinal cells of the rat
10. Localization of neuropetide-immunoreactive neurons in the human retina
11. Cholecystokinin and substance P immunoreactivity in retinas of rats, frogs, lizards and chicks
12. Substance P-like immunoreactive amacrine cells in the cat retina
13. Ontogeny of substance P-containing structures in the ocular tissue of the rat: An immunohistochemical analysis
14. Substance P-immunoreactive innervation from the retina to the suprachiasmatic nucleus in the rat
15. The morphology and topographic distribution of substance P-like immunoreactive amacrine cells in the cat retina
16. Immunohistochemical localization of substance P, enkephalin and serotonin in the developing human retina
17. Substance P-like immunoreactive amacrine cells in the adult and the developing rat retina
18. Expression and cellular localization of substance P/neurokinin A and neurokinin B mRNAs in the rat retina
19. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues
20. Localization and characterization of substance P binding sites in rat and rabbit eyes
21. Substance P in the bovine retina: Localization, identification, release, uptake, and receptor analysis
22. Neurotransmitter functions of mammalian tachykinins
23. Neurokinin 1 receptor expression in the rat retina
24. Vasoacrive intestinal peptide as a mediator of intercellular communication in the cerebral cortex. Release, receptors, actions, and interactions with norepinephrine
25. Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide
26. Glucagon and VIP in the retina
27. Substance P, vasoactive intestinal polypeptide (VIP) and somatostatin levels in ocular tissues in normal and sensorily denervated rabbit eyes
28. Retinal neurotransmitters: Histochemical and biochemical studies
29. Organization and development of sparsely distributed wide-field amacrine cells in the rabbit retina
30. Neurotransmitter candidates in the retina of the mudpuppy, Necturus maculosus
31. Vasoactive intestinal polypeptide-containing cells in the rabbit retina: Immunohistochemical localization and quantitative analysis
32. Neuropeptides in the retina:evidence of differential topographical localization
33. Localization of neuropeptides in the avian retina. An immunohistochemical analysis
34. Three dimensional analysis of retinal neuropeptides and amines in the chick
35. Discrete distribution of cholinergic and vasoactive intestinal polypeptidergic amacrine cells in the rat retina
36. Morphology and mosaics of VIP-like immunoreactive neurons in the retina of the rhesus monkey
37. VIP (vasoactive intestinal polypeptide)-immunoreactive neurons in the retina of the rat
38. A peptide histidine isoleucine/peptide histidine methionine-like peptide in the rabbit retina: Colocalization with vasoactive intestinal peptide, synaptic relationships and activation of adenylate cyclase activity
39. Vasoactive intestinal polypeptide (VIP) immunohistochemistry in the rabbit retina
40. Postnatal development of vasoactive itestinal polypeptide immunoreactive amacrine cells in the rat retina
41. VIP (vasoactive intestinal polypeptide)-like immunoreactive amacrine cells in the retina of the rat
42. Peptide immunoreactive neurons in the human retina
43. Somatostatin and VIP neurons in the retina of different spezies
44. Localization of vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in amacrine cells of rat retina
45. Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes
46. Characterization of vasoactive intestinal peptide receptors in retina
47. Co-expression of vasoactive intestinal polypeptide (VIP) with GABA in amacrine cells of rat and rabbit retinas
48. Colocalization of vasoactive intestinal polypeptide and GABA immunoreactivities in a population of wide-field amacrine cells in the rabbit retina
49. Release of secretoneurin and noradrenaline from hypothalamic slices and iistdifferential inhibition by calcium channel blockers
50. The effect of diabetes on neuropeptide content in the rat cornea and iris
51. An increase of vasoactive intestinal polypeptide-, but not neuropeptide Y-, substance P- or catecholamine-containing nerves in the iris of the streptozotocin-induced diabetic rat
52. Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas
53. The physiology of substance P in the rabbit retina
54. Effect of substance P on dopamine release in rat retina
55. Peptides influence retinal ganglion cells
56. Inner plexiform circuits in the carp retina: Effects of cholinergic agonists, GABA, and substance P on the ganglion cells
57. Light- and electron-microscopic study of substance P-immunoreactive neurons in the guinea pig retina
58. Vasoactive intestinal polypeptide modulates GABAA receptor function in bipolar cell and ganglion cells of the rat retina
59. Effects of vasoactive intestinal peptide on ganglion cells in the rabbit retina
60. The oscillatory waves of the primate electroretinogram
61. Origin of the oscillatory potentials in the primate retina
62. The oscillatory potentials of the mudpuppy retina
63. Ocular lesions in rats rendered chronically diabetic with streptozotocin
64. Experimental diabetic retinopathy
65. Dilatatin and endothelial proliferation of retinal capillaries in streptozotocin-diabetic rats
66. The role of growth factors in the development of diabetic retinopathy
67. Up-regulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
68. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy
69. Substance P induces migration of capillary endothelial cells: A novel NK-1 selective receptor mediated activity
70. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cell
71. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P